The luxury skincare brand, Galénic, now under China’s Yatsen group, is rekindling its roots by launching an endowment fund to boost dermatology research. This move is part of its efforts to solidify its standing in the luxury skincare market.
Recently, the Galénic Dermatology Research Fund honored four research projects chosen by their scientific committee at an awards ceremony held in Paris. This initiative reflects the brand’s mission, founded in 1978 by pharmacist Pierre Fabre, to fuse science and luxury beauty.
Sarah Michel-Stevens, Managing Director of Galénic Cosmetics Laboratory, highlighted the brand’s commitment to scientific excellence and its legacy of integrating science into luxury beauty.
The creation of an endowment fund and a scientific committee aims to reinforce Galénic’s identity rooted in dermatological research. Professor Jean-David Bouaziz, President of the Galenic Dermatology Research Fund Scientific Committee, expressed enthusiasm about their collaboration and its potential to advance skin physiology research.
The awarded projects include studies on autophagy’s role in the epidermal barrier, neuro-immune interactions in skin repair, enhancing the bioavailability of active ingredients for skin cancer treatment, and exploring a molecule’s role in skin aging. Each project receives 25,000 euros from the total grant of 100,000 euros.
Galénic seeks to maintain its legacy as an innovative skincare brand by collaborating with dermatology experts. This initiative aligns with their plan to launch a dedicated R&D Center in Toulouse, France.
